Literature DB >> 12621469

Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease.

P A Cane1, B G van den Hoogen, S Chakrabarti, C D Fegan, A D M E Osterhaus.   

Abstract

Respiratory viruses are increasingly recognized as a cause of pneumonitis following haematopoietic stem cell transplantation (HSCT). However, frequently, no pathogen is identified in cases of suspected viral pneumonia. Recently, a previously undescribed paramyxovirus, designated 'human metapneumovirus' (hMPV), was isolated from children with respiratory illness. We have detected hMPV as the sole pathogen in the nasopharyngeal aspirate of an HSCT recipient who succumbed to progressive respiratory failure following an upper respiratory prodrome. This report highlights the importance of further studies to elucidate the role of hMPV in causing respiratory illnesses in the HSCT population.

Entities:  

Mesh:

Year:  2003        PMID: 12621469     DOI: 10.1038/sj.bmt.1703849

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  54 in total

Review 1.  The human metapneumovirus: a case series and review of the literature.

Authors:  S Shahda; W G Carlos; P J Kiel; B A Khan; C A Hage
Journal:  Transpl Infect Dis       Date:  2010-10-03       Impact factor: 2.228

2.  Human metapneumovirus infection in a hematopoietic stem cell transplant recipient with relapsed multiple myeloma and rapidly progressing lung cancer.

Authors:  B Huck; M Egger; H Bertz; G Peyerl-Hoffman; W V Kern; D Neumann-Haefelin; V Falcone
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus In Vivo.

Authors:  Yael Bar-Peled; Darren Diaz; Alma Pena-Briseno; Jackelyn Murray; Jiachen Huang; Ralph A Tripp; Jarrod J Mousa
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

4.  Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies.

Authors:  Rodrigo Martino; Rocío Parody Porras; Nuria Rabella; John V Williams; Elena Rámila; Nuria Margall; Rosa Labeaga; James E Crowe; Pedro Coll; Jorge Sierra
Journal:  Biol Blood Marrow Transplant       Date:  2005-10       Impact factor: 5.742

5.  Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.

Authors:  Gabriella Cseke; David W Wright; Sharon J Tollefson; Joyce E Johnson; James E Crowe; John V Williams
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

Review 6.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections.

Authors:  John V Williams; Rodrigo Martino; Núria Rabella; Magdalena Otegui; Rocio Parody; Joshua M Heck; James E Crowe
Journal:  J Infect Dis       Date:  2005-08-12       Impact factor: 5.226

8.  Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice.

Authors:  M Darniot; C Pitoiset; T Petrella; S Aho; P Pothier; C Manoha
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

9.  High genetic diversity of the attachment (G) protein of human metapneumovirus.

Authors:  Nobuhisa Ishiguro; Takashi Ebihara; Rika Endo; Xiaoming Ma; Hideaki Kikuta; Hiroaki Ishiko; Kunihiko Kobayashi
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  Diagnosis of a critical respiratory illness caused by human metapneumovirus by use of a pan-virus microarray.

Authors:  Charles Y Chiu; Ash A Alizadeh; Silvi Rouskin; Jason D Merker; Elaine Yeh; Shigeo Yagi; David Schnurr; Bruce K Patterson; Don Ganem; Joseph L DeRisi
Journal:  J Clin Microbiol       Date:  2007-05-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.